Advent Life Sciences
Life sciences VC funding drug discovery, medtech, enabling technologies and vaccines
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+, Growth
- Sector focus
- Healthtech, Biotech & Life Sciences, Edtech, Hardware & Robotics
- Cheque size
- Above €3M
- Fund size
- Undisclosed
- Website
- adventls.com
Advent Life Sciences is a London-based venture firm investing in life sciences companies on both sides of the Atlantic. Its focus covers drug discovery across all modalities, medical technology, enabling technologies and vaccines.
It typically invests early, often at seed or Series A, and continues to support companies as they move into later-stage clinical development. The firm states that businesses it has backed have brought fifteen medicines and products to approval since 2006. It operates from Fitzroy Square in London and invests across the UK, Europe and the US.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.